"The Good, the Bad and the Ugly": Interplay of Innate Immunity and Inflammation

被引:1
|
作者
Aleman, Mercedes [1 ]
机构
[1] Acad Nacl Med Buenos Aires, Lab Inmunol Expt, Inst Med Expt IMEX, CONTICET, Buenos Aires, DF, Argentina
关键词
RESPIRATORY SYNCYTIAL VIRUS; GLUCAN RECEPTOR DECTIN-1; MYCOBACTERIUM-TUBERCULOSIS; RIG-I; PATHOGEN RECOGNITION; BCG VACCINATION; GUINEA-BISSAU; INFECTION; MACROPHAGE; HOST;
D O I
10.1155/2022/2759513
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Innate immunity recognizes microorganisms through certain invariant receptors named pattern recognition receptors (PRRs) by sensing conserved pathogen-associated molecular patterns (PAMPs). Their recognition activates several signaling pathways that lead the transcription of inflammatory mediators, contributing to trigger a very rapid inflammatory cascade aiming to contain the local infection as well as activating and instructing the adaptive immunity in a specific and synchronized immune response according to the microorganism. Inflammation is a coordinated process involving the secretion of cytokines and chemokines by macrophages and neutrophils leading to the migration of other leukocytes along the endothelium into the injured tissue. Sustained inflammatory responses can cause deleterious effects by promoting the development of autoimmune disorders, allergies, cancer, and other immune pathologies, while weak signals could exacerbate the severity of the disease. Therefore, PRR-mediated signal transduction must be tightly regulated to maintain host immune homeostasis. Innate immunity deficiencies and strategies deployed by microbes to avoid inflammatory responses lead to an altered immune response that allows the pathogen to proliferate causing death or uncontrolled inflammation. This review analyzes the complexity of the immune response at the beginning of the disease focusing on COVID-19 disease and the importance of unraveling its mechanisms to be considered when treating diseases and designing vaccines.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Glial inflammation: The good, the bad and the ugly
    Carson, Monica J.
    Iwasaki, Yuzo
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 45 - 45
  • [2] Mechanisms of inflammation: The good, the bad and the ugly
    Laroux, FS
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3156 - 3162
  • [3] Inflammation and Alzheimer disease: The good, the bad, and the ugly
    Weninger, SC
    Yankner, BA
    NATURE MEDICINE, 2001, 7 (05) : 527 - 528
  • [4] Inflammation and Alzheimer disease: The good, the bad, and the ugly
    Stacie C. Weninger
    Bruce A. Yankner
    Nature Medicine, 2001, 7 : 527 - 528
  • [5] Inflammation and polyamine catabolism: the good, the bad and the ugly
    Babbar, N.
    Murray-Stewart, T.
    Casero, R. A., Jr.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 300 - 304
  • [6] Commentary: The good vaccine, the bad virus, and the ugly inflammation
    Majumder, Parthopratim Dutta
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (03) : 1035 - 1036
  • [7] The good, the bad and the ugly: inflammation in epidermolysis bullosa wounds
    Bardhan, A.
    Wen, D.
    Harper, N.
    Balacco, D.
    Hirschfeld, J.
    Kuehne, S.
    Grant, M.
    Chapple, I.
    Heagerty, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 46 - 47
  • [8] Inflammation in acute myocardial infarction: the good, the bad and the ugly
    Matter, Michael A.
    Paneni, Francesco
    Libby, Peter
    Frantz, Stefan
    Stahli, Barbara E.
    Templin, Christian
    Mengozzi, Alessandro
    Wang, Yu-Jen
    Kundig, Thomas M.
    Raber, Lorenz
    Ruschitzka, Frank
    Matter, Christian M.
    EUROPEAN HEART JOURNAL, 2024, 45 (02) : 89 - 103
  • [9] Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?
    Lundvig, Ditte M. S.
    Immenschuh, Stephan
    Wagener, Frank A. D. T. G.
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [10] The good, the bad and the ugly: inflammation in epidermolysis bullosa wounds
    Bardhan, A.
    Muchova, M.
    Wen, D.
    Harper, N.
    Balacco, D.
    Hirschfeld, J.
    Kuehne, S.
    Grant, M.
    Chapple, I.
    Heagerty, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 69 - 69